SAN MARCOS, CA, UNITED STATES, May 7, 2026 /EINPresswire.com/ — We are excited to share that Everstream Analytics, the global leader in supply chain risk intelligence and predictive analytics, has ...

This alert provides a summary of a recent US Department of Justice (DOJ) anti-fraud initiative that highlights the growth of data-driven False ...

Reported positive results from aleniglipron Phase 2 ACCESS II study with up to 16.3% body weight loss, demonstrating highest efficacy among oral ...

While 3D printing revolutionized the production of static, complex geometries, 4D printing introduces time as the functional fourth dimension 1. In this paradigm, 3D-printed structures are engineered ...

Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...

Advancing Phase 3 Lasofoxifene Development Program of Novel Selective Estrogen Receptor Modulator, a Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations ...

When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...

Q1 2026 Earnings Call May 6, 2026 4:30 PM EDTCompany ParticipantsTamara Thornton - Director of Finance, Treasury ...

United Therapeutics Corporation (NASDAQ: UTHR) Q1 2026 Earnings Call Transcript May 6, 2026 United Therapeutics Corporation ...

“ The road hazard service from Bosch increases road safety while also increasing the ease of driving. Our cloud-based service ...

Good morning, and welcome to the Kinaxis Inc. Fiscal 2026 First Quarter Results Conference Call. [Operator Instructions] I'd like to remind everyone that this call is being recorded today, Thursday, ...

Peptide therapeutics require tailored ADME strategies to address stability, supporting more effective and reliable drug ...